Sernova Corp. (TSE:SVA - Get Free Report)'s stock price was down 2.5% on Tuesday . The stock traded as low as C$0.19 and last traded at C$0.20. Approximately 221,125 shares were traded during trading, an increase of 57% from the average daily volume of 140,500 shares. The stock had previously closed at C$0.20.
Sernova Stock Performance
The business has a 50 day moving average price of C$0.21 and a 200 day moving average price of C$0.24. The company has a market capitalization of C$67.30 million, a P/E ratio of -1.93 and a beta of 1.35. The company has a current ratio of 0.32, a quick ratio of 18.11 and a debt-to-equity ratio of -4.40.
Sernova Company Profile
(
Get Free Report)
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Featured Stories
Before you consider Sernova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sernova wasn't on the list.
While Sernova currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
